Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Wyszukujesz frazę ""Martino M"" wg kryterium: Autor


Tytuł:
Cost-effectiveness of on-demand plerixafor added to chemotherapy and granulocyte-colony stimulating factor for peripheral blood stem cell mobilization in multiple myeloma.
Autorzy:
Milone G; a Hematology and BMT UNIT , Azienda Policlinico Vittorio Emanuele , Catania , Italy.
Martino M; b Hematology and BMT UNIT , Ospedale Bianco Melacrino Morelli , Reggio Calabria , Italy.
Leotta S; a Hematology and BMT UNIT , Azienda Policlinico Vittorio Emanuele , Catania , Italy.
Spadaro A; a Hematology and BMT UNIT , Azienda Policlinico Vittorio Emanuele , Catania , Italy.
Zammit V; a Hematology and BMT UNIT , Azienda Policlinico Vittorio Emanuele , Catania , Italy.
Cupri A; a Hematology and BMT UNIT , Azienda Policlinico Vittorio Emanuele , Catania , Italy.
Avola G; a Hematology and BMT UNIT , Azienda Policlinico Vittorio Emanuele , Catania , Italy.
Camuglia MG; a Hematology and BMT UNIT , Azienda Policlinico Vittorio Emanuele , Catania , Italy.
Di Marco A; a Hematology and BMT UNIT , Azienda Policlinico Vittorio Emanuele , Catania , Italy.
Scalzulli P; c Hematology and BMT UNIT , Ospedale Sollievo Sofferenza , San Giovanni Rotondo , Italy.
Morelli M; d Hematology and BMT UNIT , H San Raffaele , Milano , Italy.
Olivieri A; e Hematology and BMT UNIT , Universita delle Marche , Ancona , Italy.
Tripepi G; f Istituto di Fisiologia Clinica, CNR , Reggio Calabria , Italy.
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2018 Jan; Vol. 59 (1), pp. 42-48. Date of Electronic Publication: 2017 Jun 02.
Typ publikacji:
Clinical Trial, Phase II; Clinical Trial, Phase III; Journal Article
MeSH Terms:
Hematopoietic Stem Cell Mobilization*/methods
Hematopoietic Stem Cell Transplantation*/adverse effects
Hematopoietic Stem Cell Transplantation*/methods
Antineoplastic Combined Chemotherapy Protocols/*therapeutic use
Multiple Myeloma/*therapy
Peripheral Blood Stem Cells/*drug effects
Algorithms ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Benzylamines ; Case-Control Studies ; Cost-Benefit Analysis ; Cyclams ; Cyclophosphamide/administration & dosage ; Disease Management ; Graft Survival ; Granulocyte Colony-Stimulating Factor/administration & dosage ; Heterocyclic Compounds/administration & dosage ; Humans ; Peripheral Blood Stem Cells/cytology ; Peripheral Blood Stem Cells/metabolism ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Selective targeting of IRF4 by synthetic microRNA-125b-5p mimics induces anti-multiple myeloma activity in vitro and in vivo.
Autorzy:
Morelli E; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
Leone E; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
Cantafio ME; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
Di Martino MT; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
Amodio N; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
Biamonte L; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
Gullà A; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
Foresta U; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
Pitari MR; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
Botta C; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
Rossi M; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
Neri A; Department of Medical Sciences, University of Milan, Hematology 1, IRCCS Policlinico Foundation, Milan, Italy.
Munshi NC; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.; VA Boston Healthcare System, West Roxbury, Boston, MA, USA.
Anderson KC; Jerome Lipper Multiple Myeloma Center, Department of Medical Oncology, Dana-Farber Cancer Institute, Boston, MA, USA.
Tagliaferri P; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.
Tassone P; Department of Experimental and Clinical Medicine, Magna Graecia University, Salvatore Venuta University Campus, Catanzaro, Italy.; Sbarro Institute for Cancer Research and Molecular Medicine, Center for Biotechnology, College of Science and Technology, Temple University, Philadelphia, PA, USA.
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2015 Nov; Vol. 29 (11), pp. 2173-83. Date of Electronic Publication: 2015 May 19.
Typ publikacji:
Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't; Research Support, U.S. Gov't, Non-P.H.S.
MeSH Terms:
Interferon Regulatory Factors/*genetics
MicroRNAs/*physiology
Multiple Myeloma/*therapy
Animals ; Apoptosis ; Autophagy ; Cell Line, Tumor ; Cell Proliferation ; Genes, Tumor Suppressor/physiology ; Humans ; Male ; Mice ; Multiple Myeloma/pathology
Czasopismo naukowe
Tytuł:
A home-care, early discharge model after autografting in multiple myeloma: results of a three-arm prospective, non-randomized study.
Autorzy:
Martino M; Hematology and Transplant Unit.
Russo L
Martinello T
Gallo GA
Fedele R
Moscato T
Console G
Vincelli DI
Ronco F
Postorino M
Irrera G
Messina G
Pokaż więcej
Źródło:
Leukemia & lymphoma [Leuk Lymphoma] 2015 Mar; Vol. 56 (3), pp. 801-4. Date of Electronic Publication: 2014 Jul 17.
Typ publikacji:
Letter
MeSH Terms:
Home Care Services*
Outpatients*
Multiple Myeloma/*therapy
Stem Cell Transplantation/*methods
Adult ; Aged ; Antineoplastic Agents, Alkylating/therapeutic use ; Combined Modality Therapy ; Febrile Neutropenia/etiology ; Female ; Humans ; Male ; Melphalan/adverse effects ; Melphalan/therapeutic use ; Middle Aged ; Non-Randomized Controlled Trials as Topic ; Prospective Studies ; Stem Cell Transplantation/adverse effects ; Transplantation, Autologous ; Treatment Outcome
Opinia redakcyjna
Tytuł:
A unique three-dimensional SCID-polymeric scaffold (SCID-synth-hu) model for in vivo expansion of human primary multiple myeloma cells.
Autorzy:
Calimeri T
Battista E
Conforti F
Neri P
Di Martino MT
Rossi M
Foresta U
Piro E
Ferrara F
Amorosi A
Bahlis N
Anderson KC
Munshi N
Tagliaferri P
Causa F
Tassone P
Pokaż więcej
Źródło:
Leukemia [Leukemia] 2011 Apr; Vol. 25 (4), pp. 707-11. Date of Electronic Publication: 2011 Jan 14.
Typ publikacji:
Letter; Research Support, Non-U.S. Gov't
MeSH Terms:
Disease Models, Animal*
Bone Marrow/*pathology
Multiple Myeloma/*pathology
Polymers/*chemistry
Stromal Cells/*pathology
Animals ; Bone Marrow/metabolism ; Bone Marrow/ultrastructure ; Cell Culture Techniques ; Cells, Cultured ; Enzyme-Linked Immunosorbent Assay ; Female ; Humans ; Male ; Mice ; Mice, SCID ; Multiple Myeloma/metabolism ; Stromal Cells/metabolism ; Stromal Cells/ultrastructure
Raport
Tytuł:
Low tolerance and high toxicity of thalidomide as maintenance therapy after double autologous stem cell transplant in multiple myeloma patients.
Autorzy:
Martino M; Department of Bone Marrow Transplant, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy. />Console G
Callea V
Stelitano C
Massara E
Irrera G
Messina G
Morabito F
Iacopino P
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2007 Jan; Vol. 78 (1), pp. 35-40. Date of Electronic Publication: 2006 Oct 17.
Typ publikacji:
Clinical Trial; Journal Article
MeSH Terms:
Hematopoietic Stem Cell Transplantation*
Antineoplastic Agents/*adverse effects
Multiple Myeloma/*therapy
Thalidomide/*adverse effects
Adult ; Disease Progression ; Disease-Free Survival ; Dose-Response Relationship, Drug ; Drug Tolerance ; Female ; Humans ; Male ; Middle Aged ; Survival Rate ; Transplantation, Autologous ; Treatment Outcome
Czasopismo naukowe
Tytuł:
Pegfilgrastim compared with filgrastim after high-dose melphalan and autologous hematopoietic peripheral blood stem cell transplantation in multiple myeloma patients.
Autorzy:
Martino M; Bone Marrow Transplant Unit, Azienda Ospedaliera Bianchi-Melacrino-Morelli, Reggio Calabria, Italy. />Praticò G
Messina G
Irrera G
Massara E
Messina G
Console G
Iacopino P
Pokaż więcej
Źródło:
European journal of haematology [Eur J Haematol] 2006 Nov; Vol. 77 (5), pp. 410-5. Date of Electronic Publication: 2006 Aug 23.
Typ publikacji:
Clinical Trial; Comparative Study; Journal Article; Randomized Controlled Trial
MeSH Terms:
Peripheral Blood Stem Cell Transplantation*/adverse effects
Granulocyte Colony-Stimulating Factor/*administration & dosage
Melphalan/*administration & dosage
Multiple Myeloma/*therapy
Myeloablative Agonists/*administration & dosage
Neutropenia/*drug therapy
Aged ; Antineoplastic Combined Chemotherapy Protocols/administration & dosage ; Antineoplastic Combined Chemotherapy Protocols/adverse effects ; Dacarbazine/administration & dosage ; Dacarbazine/adverse effects ; Female ; Filgrastim ; Hematopoiesis/drug effects ; Humans ; Infection Control/methods ; Infections/etiology ; Male ; Middle Aged ; Multiple Myeloma/complications ; Neutropenia/etiology ; Nimustine/administration & dosage ; Nimustine/adverse effects ; Polyethylene Glycols ; Recombinant Proteins ; Recovery of Function/drug effects ; Time Factors ; Transplantation, Autologous ; Vincristine/administration & dosage ; Vincristine/adverse effects
SCR Protocol:
DAV protocol
Czasopismo naukowe

Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies